IRIS
DE MARIA, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 30.764
AS - Asia 3.042
NA - Nord America 1.498
SA - Sud America 255
AF - Africa 56
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 35.622
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 30.252
US - Stati Uniti d'America 1.393
SG - Singapore 1.361
CN - Cina 789
VN - Vietnam 526
FR - Francia 256
BR - Brasile 162
HK - Hong Kong 107
BD - Bangladesh 82
FI - Finlandia 65
DE - Germania 61
AR - Argentina 48
CA - Canada 40
MX - Messico 40
JP - Giappone 31
CH - Svizzera 23
GB - Regno Unito 23
IN - India 21
ID - Indonesia 18
IQ - Iraq 18
NL - Olanda 16
ZA - Sudafrica 16
PH - Filippine 13
EC - Ecuador 12
ES - Italia 11
TW - Taiwan 11
KR - Corea 10
KE - Kenya 9
VE - Venezuela 9
PK - Pakistan 8
SA - Arabia Saudita 8
PY - Paraguay 7
TR - Turchia 7
CO - Colombia 6
DZ - Algeria 6
IE - Irlanda 6
MA - Marocco 6
TN - Tunisia 6
AU - Australia 5
CL - Cile 5
JM - Giamaica 5
RU - Federazione Russa 5
UZ - Uzbekistan 5
AT - Austria 4
HN - Honduras 4
JO - Giordania 4
MY - Malesia 4
PL - Polonia 4
RS - Serbia 4
AE - Emirati Arabi Uniti 3
EG - Egitto 3
GT - Guatemala 3
HU - Ungheria 3
KZ - Kazakistan 3
NP - Nepal 3
SK - Slovacchia (Repubblica Slovacca) 3
UA - Ucraina 3
UY - Uruguay 3
AL - Albania 2
BE - Belgio 2
BG - Bulgaria 2
BO - Bolivia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
IL - Israele 2
MD - Moldavia 2
MK - Macedonia 2
MT - Malta 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
PR - Porto Rico 2
PS - Palestinian Territory 2
PT - Portogallo 2
SI - Slovenia 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BZ - Belize 1
CI - Costa d'Avorio 1
CM - Camerun 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
ET - Etiopia 1
GA - Gabon 1
GR - Grecia 1
HR - Croazia 1
KY - Cayman, isole 1
LB - Libano 1
LT - Lituania 1
MF - Saint Martin 1
MM - Myanmar 1
MN - Mongolia 1
PA - Panama 1
PE - Perù 1
RE - Reunion 1
SE - Svezia 1
SN - Senegal 1
SV - El Salvador 1
TG - Togo 1
Totale 35.618
Salva come PNG Salva come JPEG
Città #
Genova 18.092
Genoa 7.381
Rapallo 2.776
Vado Ligure 1.777
Singapore 644
San Jose 505
Lauterbourg 243
Ho Chi Minh City 160
Ashburn 124
Beijing 107
Hanoi 105
New York 104
Hong Kong 103
Helsinki 63
Council Bluffs 61
Bordighera 50
Frankfurt am Main 47
Santa Clara 35
Tokyo 28
Los Angeles 27
Mexico City 26
Milan 26
Haiphong 23
Zurich 23
Da Nang 21
Atlanta 18
Tianjin 18
Chicago 15
Orem 14
Rome 13
São Paulo 13
Biên Hòa 12
Buffalo 12
City of London 12
Amsterdam 11
San Francisco 11
Guangzhou 10
Des Moines 8
Montreal 8
Dallas 7
Houston 7
Hải Dương 7
Nairobi 7
Shanghai 7
Baghdad 6
Bari 6
Buenos Aires 6
Dublin 6
Johannesburg 6
Naples 6
Nuremberg 6
Phủ Lý 6
Bắc Ninh 5
Cape Town 5
Curitiba 5
Dammam 5
Madrid 5
Phoenix 5
Rio de Janeiro 5
Sydney 5
Thái Nguyên 5
Toronto 5
Amman 4
Boardman 4
Campinas 4
Dhaka 4
Marseille 4
Mumbai 4
Phủ Từ Sơn 4
Porto Alegre 4
Santa Rosa 4
Shenzhen 4
Turin 4
Wuhan 4
Xi'an 4
Alexandria 3
Belgrade 3
Brooklyn 3
Bắc Giang 3
Can Tho 3
Charlotte 3
Chennai 3
Davao City 3
Denver 3
Düsseldorf 3
Elk Grove Village 3
Florence 3
Go Vap 3
Guayaquil 3
Jacksonville 3
Jakarta 3
Karachi 3
Kuala Lumpur 3
Kyiv 3
Lahore 3
London 3
Maceió 3
Medellín 3
Miami 3
Miano 3
Totale 32.986
Salva come PNG Salva come JPEG
Nome #
A modular framework for the development of targeted Covid-19 blood transcript profiling panels 340
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 330
The Ligurian Human Immunodeficiency Virus Clinical Network: A Web Tool to Manage Patients With Human Immunodeficiency Virus in Primary Care and Multicenter Clinical Trials 243
Evaluation of Frequency of CMV Replication and Disease Complications Reveals New Cellular Defects and a Time Dependent Pattern in CVID Patients 225
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. 215
Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreak 205
Analysis of clinical management of infected breast implants and of factors associated to successful breast pocket salvage in infections occurring after breast reconstruction 202
'Emergency exit' of bone-marrow-resident CD34+ DNAM-1 bright CXCR4+-committed lymphoid precursors during chronic infection and inflammation 200
Il sistema TIDA nell'emicrania: effetto della nomifensina sulla secrezione di prolattina 198
Human NK cell receptors/markers: A tool to analyze NK cell development, subsets and function. 193
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 193
Use of maraviroc in clinical practice: a multicenter observational study 192
Pregnancy and neonatal outcomes among a cohort of HIV-infected women in a large Italian teaching hospital: a 30-year retrospective study 190
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 189
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More 184
Phenotypic and genotypic characterization of Staphylococci causing breast peri-implant infections in oncologic patients. 181
Rete Ligure dell’HIV: due anni di esperienza nella gestione del dato clinico 180
Factors associated with HIV RNA levels in pregnant women on non-suppressive highly active antiretroviral therapy at conception 179
Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment. 179
Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation. 178
Functionally relevant decreases in activatory receptor expression on NK cells are associated with pulmonary tuberculosis in vivo and persist after successful treatment. 177
Chemotherapy Mass Campaigns and Migratory Flows: An Unexpected Connection 177
Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy 177
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 177
Are there Gender and Race Differences in cellular immunity patterns over age in infected and uninfected children born to HIV-1 infected women? 176
Bloodstream infections in critically ill patients with COVID-19 175
HCV-related polyradiculoneuropathy in a HIV-positive man 174
Conserved T cell and natural killer cell function in treatment-experienced adults receiving tenofovir plus didanosine reverse transcription inhibitor backbone 171
Analysis of NK cell function and receptor expression during HTLV-1 and HTLV-2 infection 170
Early versus late treatment with Zidovudine 170
Incidence and immunomic features of apyretic COVID-19 in patients affected by solid tumors: a prospective cohort study 169
Adhesion of human neuroblasts to HIV-1 tat. 169
Seasonal and pandemic (A/H1N1 2009) MF-59-adjuvanted influenza vaccines in complete remission non-Hodgkin lymphoma patients previously treated with rituximab containing regimens. 169
Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA < 50 cp/mL 168
Popolazione di precursori linfoidi umani, metodo per la loro identificazione e relativi usi 167
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 167
Empirical first-line treatment with tigecycline for febrile episodes following abdominal surgery in cancer patients 165
Use of Neonatal Antiretroviral Prophylaxis for Prevention of Mother‐to‐Child Transmission of HIV Is Decreasing in Western Europe 165
Insufficient antiretroviral therapy in pregnancy: missed opportunities for prevention of mother-to- child transmission of HIV in Europe 165
Breast implant infection due to Paenibacillus residui in a cancer patient 165
Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients 164
Absence of HIV-1 after treatment cessation in an infant. 163
Clinical and Microbiological Characterization of Late Breast Implant Infections after Reconstructive Breast Cancer Surgery 162
Accuracy of HCV-RNA PCR tests for diagnosis or exclusion of vertically acquired HCV infection. 160
Successfully treated HIV-infected patients have differential expression of NK cell receptors (NKp46 and NKp30) according to AIDS status at presentation. 160
Does exposure to antiretroviral therapy affect growth in the first 18 months of life in uninfected children born to HIV-infected women? 159
HTLV-1/-2 and HIV-1 co-infections: retroviral interference on host immune status. 159
Effects on growth after switching protease inhibitors to efavirenz in HIV-1-infected children 158
Human NK Cells and Herpesviruses: Mechanisms of Recognition, Response and Adaptation 158
The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication. 157
Are girls more at risk of intrauterine-acquired HIV infection than boys? 157
Breast Implant Infections after Surgical Reconstruction in Patients with Breast Cancer: Assessment of Risk Factors and Pathogens over Extended Post-Operative Observation. 156
Baseline and Dynamic Expression of Activating NK Cell Receptors in the Control of Chronic Viral Infections: The Paradigm of HIV-1 and HCV. 154
Children born to women with HIV-1 infection: natural history and risk of transmission 151
Clinically stable treatment-experienced adults receiving tenofovir and didanosine. 151
Age-related standards for T-lymphocye subsets based on uninfected children born to human immunodeficiency virus 1-infected women 150
Patients Treated with Rituximab-Containing Immunochemotherapy Have a Significant and Prolonged Lack of Humoral Response to Influenza Vaccine Associated with a Persistent Depletion of B Memory Cells 150
Unsung hero Robert C. Gallo 150
Expression of HLA-class I-specific inhibitory Natural Killer cell receptors in HIV-specific cytolytic T lymphocytes. Impairment of specific cytolytic functions. 149
Late symptomatic neurosyphilis presenting as a motor polyradiculoneuropathy. 149
Unusual presentation of visceral leishmaniasis in an HIV-infected patient. 149
Control of the HIV-1 DNA reservoir is associated in vivo and in vitro with NKp46/NKp30 (CD335 CD337) inducibility and interferon gamma production by transcriptionally unique NK cells 149
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 149
Distinctive lack of CD48 expression in subsets of human dendritic cells tunes NK cell activation. 148
Correction to: Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy (Infection, 10.1007/s15010-017-1063-7) 148
HLA-class I-specific inhibitory receptors in HIV-1 infection. 147
NK cell receptors and their interactions with MHC. 147
NK-cell phenotype at interruption underlies widely divergent duration of CD4+-guided antiretroviral treatment interruption. 147
Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab era 147
Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients. 146
Inherent transcriptional signatures of NK cells are associated with response to IFNΑ+rivabirin therapy in patients with Hepatitis C Virus 146
Age-related lymphocyte and neutrophil levels in children of hepatitis C-infected women 145
Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1 infected patients 144
Involvement of activating NK cell receptors and their modulation in pathogen immunity. 144
Improvements in virological control among women conceiving on combination antiretroviral therapy in Western Europe. 144
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 144
HIV serological screening in a population of pregnant women in the Republic of Congo: suitability of different assays 143
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 143
A mature NK profile at the time of HIV primary infection is associated with an early response to cART 143
Receptor modulation and functional activation of human CD34(+) Lin(-) -derived immature NK-cells in vitro by Mycobacterium Bovis Calmette-Guerin (BCG). 143
Perinatal findings in children born to HIV-infected mothers 141
Immunology of tuberculosis. 141
Low expression of inhibitory natural killer receptors in CD8 cytotoxic T lymphocytes in long-term non-progressor HIV-1-infected patients 141
Levels and patterns of neutrophil cell counts over the first 8 years of life in children of HIV-1-infected mothers. 141
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 141
Varied spectrum of clinical presentation and mortality in a prospective registry of visceral leishmaniasis in a low endemicity area of Northern Italy. 140
Detection of virus in vertically exposed HIV-antibody-negative children. 139
Benserazide effects on growth hormone, prolactin, and thyrotropin in normal and acromegalic man. 139
Management of fever in children: summary of the Italian Pediatric Society guidelines. 139
Natural killer cell development and maturation revisited: Possible implications of a novel distinct Lin-CD34+DNAM-1brightCXCR4+ cell progenitor 139
Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV-infected pregnant women. 139
Pre-filled normal saline syringes to reduce totally implantable venous access device-associated bloodstream infection: a single institution pilot study. 138
Early active tuberculosis in gold miners who undergo HIV seroconversion: should it influence general practice? 137
Changes in the dopaminergic control of prolactin secretion and in ovarian steroids in migraine. 137
Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. 137
Modulation of CD112 by the alphaherpesvirus gD protein suppresses DNAM-1-dependent NK cell-mediated lysis of infected cells. 137
NK cell function in HIV-1 infection 137
Weight, height and human immunodeficiency virus infection in young children of infected mothers 137
Detection of CD8 T-cell expansions with restricted T-cell receptor V gene usage in infants vertically infected by HIV-1. 137
Innate immunity cell activation in virologically suppressed HIV-infected maraviroc-treated patients 137
Totale 16.416
Salva come PNG Salva come JPEG
Categoria #
all - tutte 111.051
article - articoli 100.223
book - libri 338
conference - conferenze 1.684
curatela - curatele 0
other - altro 0
patent - brevetti 1.192
selected - selezionate 0
volume - volumi 7.614
Totale 222.102
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021129 0 0 0 0 0 0 0 0 0 0 0 129
2021/20223.077 75 185 200 365 154 281 161 736 136 316 80 388
2022/20233.365 340 203 44 311 487 648 56 236 537 104 345 54
2023/20241.488 80 252 37 149 123 236 51 117 100 51 97 195
2024/20254.768 144 373 135 239 627 473 397 767 204 244 427 738
2025/20267.973 947 250 727 676 1.005 805 1.269 375 558 755 387 219
Totale 35.870